A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations
尽管耐药水平存在差异且缺乏常见的gp120耐药突变,但临床上HIV-1对CCR5拮抗剂马拉维罗克产生耐药性的常见机制
期刊:Retrovirology
影响因子:3.9
doi:10.1186/1742-4690-10-43
Roche, Michael; Salimi, Hamid; Duncan, Renee; Wilkinson, Brendan L; Chikere, Kelechi; Moore, Miranda S; Webb, Nicholas E; Zappi, Helena; Sterjovski, Jasminka; Flynn, Jacqueline K; Ellett, Anne; Gray, Lachlan R; Lee, Benhur; Jubb, Becky; Westby, Mike; Ramsland, Paul A; Lewin, Sharon R; Payne, Richard J; Churchill, Melissa J; Gorry, Paul R